Gregory Downey
National Jewish Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Gregory Downey as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:37 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04598919 · Saracatinib in the Treatment of Idiopathic Pulmonary FibrosisNational Jewish Health · active not recruiting · Idiopathic Pulmonary Fibrosis (IPF) · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- 1/2 Efficacy and Safety of Obinutuzumab in Connective Tissue Disease-Related Interstitial Lung DiseaseUG3HL183035 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2026 · $1,000,770 awarded in 2026Same name and institution; not confirmed by an ID
- Proteolysis in the Pathogenesis of ARDSR01HL157424 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2022 to 2025 · $683,217 awarded in 2025Same name and institution; not confirmed by an ID
- Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary FibrosisUH3TR002445 · NCATS · NATIONAL JEWISH HEALTH · fiscal years 2019 to 2021 · $1,511,058 awarded in 2021Same name and institution; not confirmed by an ID
- Checkpoint Function of PTPalpha in Pathological Fibrogenesis in the LungR01HL132950 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2016 to 2019 · $495,899 awarded in 2019Same name and institution; not confirmed by an ID
- Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary FibrosisUG3TR002445 · NCATS · NATIONAL JEWISH HEALTH · fiscal years 2018 · $853,963 awarded in 2018Grant number is on one of their registry trials
- Targeting PTPalpha to Prevent Lung FibrosisR21ES023932 · NIEHS · NATIONAL JEWISH HEALTH · fiscal years 2014 to 2015 · $198,125 awarded in 2015Same name and institution; not confirmed by an ID
- Focal Adhesion Modulation of IL-1 Signaling: Importance in Pulmonary FibrosisR01HL090669 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 2008 to 2011 · $390,000 awarded in 2011Same name and institution; not confirmed by an ID
- PROSTAGLANDINS AND NEUTROPHIL-MEDIATED LUNG INJURYK08HL002039 · NHLBI · NATIONAL JEWISH HEALTH · fiscal years 1987 · $54,000 awarded in 1987Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:37 UTC. The ranking covers the 200 most relevant of 26 PubMed records, and a shared surname and initials can bring in a namesake. All 26 on PubMed
- Efficacy and safety of sirolimus in lymphangioleiomyomatosis.N Engl J Med · 2011865 citationsRCR 22.6
- Implications of rejection sensitivity for intimate relationships.J Pers Soc Psychol · 1996711 citationsRCR 29.6
- The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis.Nephrol Dial Transplant · 2011424 citationsRCR 14.3
- Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III-IV melanoma.J Immunother Cancer · 2019381 citationsRCR 13.4
- The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans.Physiol Genomics · 2004289 citationsRCR 7.2
- 241 citationsRCR 19.4
- 169 citationsRCR 5.4
- Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.N Engl J Med · 2024131 citationsRCR 15.6
- Temsirolimus with or without megestrol acetate and tamoxifen for endometrial cancer: a gynecologic oncology group study.Gynecol Oncol · 201496 citationsRCR 2.9
- DEET mosquito repellent provides personal protection against malaria: a household randomized trial in an Afghan refugee camp in Pakistan.Trop Med Int Health · 200482 citationsRCR 2.8